Stock-Based Compensation (Annual)

Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.

Viemed Healthcare, Inc. (VMD) had Stock-Based Compensation of $9.13M for the most recently reported fiscal year, ending 2025-12-31.

Quarterly Annual

Figures for fiscal year ending 2025-12-31

Income Statement Financials
Revenue	$270.28M
Net Income	$14.93M
Cost of Goods Sold	$114.82M
Gross Profit	$155.46M
Operating Expenses	$249.82M
Operating Income	$20.46M
Non-Operating Income/Expense	$1.31M
Pre-Tax Income	$21.77M
Normalized Pre-Tax Income	$19.53M
Income after Taxes	$15.38M
Income from Continuous Operations	$15.38M
Consolidated Net Income/Loss	$15.38M
Normalized Income after Taxes	$12.48M
EBIT	$20.46M
EBITDA	$49.30M
Weighted-Average Shares Outstanding (Basic)	38.90M
Weighted-Average Shares Outstanding (Diluted)	40.82M
Earnings per Share (EPS) (Basic)	$0.38
Earnings per Share (EPS) (Diluted)	$0.37
Balance Sheet Financials
Current Assets	$48.49M
Property, Plant, and Equipment	$78.78M
Long-Term Assets	$150.66M
Total Assets	$199.15M
Current Liabilities	$41.06M
Long-Term Debt	$11.29M
Long-Term Liabilities	$14.58M
Total Liabilities	$55.63M
Common Equity	$143.52M
Tangible Shareholders Equity	$83.30M
Shareholders Equity	$143.52M
Common Shares Outstanding	38.02M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$51.92M
Cash Flow from Investing Activities	$-50.17M
Cash Flow from Financial Activities	$-5.79M
Beginning Cash	$17.54M
End Cash	$13.50M
Increase/Decrease in Cash	$-4.04M
Stock-Based Compensation	$9.13M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.18
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.07
Debt to Equity Ratio	0.09
Gross Margin	57.52%
Operating Margin	7.57%
EBIT Margin	7.57%
EBITDA Margin	18.24%
Pre-Tax Profit Margin	8.05%
Profit Margin	5.53%
Free Cash Flow	$28.08M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	1.36
Inventory Turnover	22.75
Receiveable Turnover	10.47
Days Sales in Receivables	34.86
Return on Equity	10.71%
Return on Tangible Equity	18.46%
Return on Assets	7.72%
Return on Investments	9.93%
Book Value Per Share	$3.77
Free Cash Flow per Share	$0.69
Operating Cash Flow per Share	$1.27

Data from Zacks Investment Research, Inc.